Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07511413

GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients

An Observational Study on Longitudinal Nutritional Status and Body Composition Changes in Head and Neck Cancer, Lung Cancer and Rectal Cancer Patients During Antineoplastic Treatments

Status
Recruiting
Phase
Study type
Observational
Enrollment
110 (estimated)
Sponsor
Fondazione del Piemonte per l'Oncologia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

GALENOS 1 is a prospective observational study designed to explore longitudinal changes in nutritional status and body composition in patients with head and neck squamous cell carcinoma, locally advanced rectal cancer, and lung cancer undergoing standard antineoplastic treatments. The study is the preparatory observational component of the FOR-GALE PREVENTION project, which aims to support the future development of a galenic immunonutrition dietary supplement intended to reduce adverse events and improve treatment compliance

Detailed description

This single-center prospective observational cohort study will enroll adult patients with pathologically confirmed head and neck squamous cell carcinoma, locally advanced rectal cancer, or lung cancer who are candidates for standard antineoplastic treatment according to routine clinical practice. The study will longitudinally assess nutritional intake, anthropometric and body composition parameters, muscle function, circulating cytokines, quality of life, treatment-related toxicity, and treatment tolerance. Study procedures include dietary visits, 3-day food records, nutritional screening, bioimpedance analysis, handgrip testing, cytokine sampling, quality-of-life questionnaires, and collection of treatment adherence/tolerance data at predefined time points from baseline through follow-up. The study aims to generate observational data to inform future immunonutritional interventional studies

Conditions

Timeline

Start date
2024-09-23
Primary completion
2027-08-30
Completion
2027-12-30
First posted
2026-04-06
Last updated
2026-04-06

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07511413. Inclusion in this directory is not an endorsement.